Since IL-13Rα2 expression is relatively high in metastatic prostate cancer cells, we assessed in vitro the potential of Pep-1-Phor21 as a therapeutic drug for prostate cancer. This evidence concerns the gene IL13RA2 and prostate carcinoma.